Accordingly, KTS is thought to lie on the PIK3CA-related overgrowth spectrum (PROS) [4, 5], but reports are limited [3, 6–9] and genetic differences among races are unknown. The gene discussed is PIK3CA; the disease is angioosteohypertrophic syndrome.